Kalen Sundeen
Physician Assistant · Cloverdale, INNPI 1366000671
Payments from drug & device makers
Across 397 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$701
- Lilly USA, LLC$568
- GSK$444
- AstraZeneca$435
- Amgen$323
- plus $3K from 34 others
What the payments were for
- Food & beverage$6,765100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEXSERO$125
How this compares
$6,765 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 48 | $51,991 |
| TrulicityDulaglutide | 37 | $48,120 |
| OzempicSemaglutide | 38 | $39,206 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $31,938 |
| MounjaroTirzepatide | 25 | $27,027 |
| EntrestoSacubitril/Valsartan | 13 | $21,821 |
| FarxigaDapagliflozin Propanediol | 21 | $19,385 |
| Nurtec OdtRimegepant Sulfate | 15 | $17,693 |
| RexultiBrexpiprazole | 12 | $17,579 |
| MyrbetriqMirabegron | 25 | $14,332 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 93 | $2,595 |
| Duloxetine Hcl | 62 | $1,509 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $1,342 |
| Gabapentin | 132 | $1,322 |
| Atorvastatin Calcium | 190 | $1,051 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $568 | $75,43276 claims |
| Boehringer IngelheimJardiance | $172 | $51,99148 claims |
| Novo NordiskOzempic | $701 | $39,20638 claims |
| GSKTrelegy Ellipta | $444 | $31,93835 claims |
| NovartisEntresto | $251 | $21,82113 claims |
| AstraZenecaFarxiga | $435 | $19,38521 claims |
| PfizerNurtec Odt | $240 | $17,69315 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $225 | $17,57912 claims |
| Astellas Pharma US IncMyrbetriq | $81 | $14,33225 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $67292 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Cloverdale
- Jessica StewartCloverdale$7K
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.